oxymatrine has been researched along with Infarction, Middle Cerebral Artery in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jianqiang, Y; Lin, M; Ning, J; Ningtian, M; Qingluan, Z; Ru, Z; Rui, C; Tao, S; Yinju, H; Yuxiang, L | 1 |
| Du, J; Hao, YJ; Jin, SJ; Lei, Z; Li, J; Li, YX; Sun, T; Wang, J; Wang, SJ; Wang, TF; Wang, YS; Yu, JQ; Zhou, R | 1 |
| He, MT; Jing, L; Ma, YM; Wang, R; Wang, WJ; Zhang, DH; Zhang, JZ | 1 |
| Fan, HG; Liu, Y; Yang, CH; Zhang, XJ | 1 |
| Fan, H; Li, L; Liu, Y; Yang, C; Yang, Y; Yin, J; Zhang, X | 1 |
| Cui, L; Du, W; Li, M; Liu, L; Wang, L; Yang, R; Zhang, X | 1 |
6 other study(ies) available for oxymatrine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Anti-apoptotic and neuroprotective effects of oxysophoridine on cerebral ischemia both in vivo and in vitro.
Topics: Alkaloids; Animals; Apoptosis; bcl-2-Associated X Protein; Brain; Brain Ischemia; Caspase 3; Cytochromes c; Hippocampus; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred ICR; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 2013 |
Oxysophoridine protects against focal cerebral ischemic injury by inhibiting oxidative stress and apoptosis in mice.
Topics: Alkaloids; Animals; Apoptosis; Brain Ischemia; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred ICR; Oxidative Stress; Reperfusion Injury | 2013 |
Oxymatrine Alleviates Hyperglycemic Cerebral Ischemia/Reperfusion Injury via Protecting Microvessel.
Topics: Alkaloids; Animals; Apoptosis; Brain Ischemia; Endothelial Cells; Humans; Infarction, Middle Cerebral Artery; Microvessels; Quinolizines; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2022 |
Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-kappaB expression.
Topics: Alkaloids; Animals; Body Water; Brain; Brain Edema; Cell Nucleus; Cytoplasm; Down-Regulation; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; NF-kappa B; Quinolizines; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription Factor RelA | 2009 |
Oxymatrine downregulates TLR4, TLR2, MyD88, and NF-kappaB and protects rat brains against focal ischemia.
Topics: Alkaloids; Animals; Anti-Arrhythmia Agents; Brain; Brain Ischemia; Infarction, Middle Cerebral Artery; Male; Molecular Structure; Myeloid Differentiation Factor 88; Neuroprotective Agents; NF-kappa B; Quinolizines; Rats; Rats, Sprague-Dawley; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2009 |
Neuroprotection and underlying mechanisms of oxymatrine in cerebral ischemia of rats.
Topics: Alkaloids; Analysis of Variance; Animals; Arachidonate 15-Lipoxygenase; Brain Edema; Brain Infarction; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Phospholipases A2, Cytosolic; Quinolizines; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2011 |